Anthropic formally began its public-market push by filing an S-1 for a proposed Nasdaq listing under the ticker ANT. The company has not set the number of shares or price range, and stressed that the registration statement is not yet effective.¹

The prospectus frames the moment as bigger than a conventional IPO. Anthropic says AI could speed scientific discovery, lift economic growth and help cure disease, but argues those gains must be pursued while preventing the harms of a technology moving at exceptional speed. “We believe that AI is one of the most consequential technologies in human history,” the company wrote.²

Then comes the balance-sheet jolt. For the first six months of 2026, Anthropic reported $16.3 billion in revenue — about 13.5 times its year-earlier level — alongside an $80.7 billion net loss. The headline deficit was driven largely by a $72.4 billion accounting charge tied to the rising value of convertible notes, while operating losses narrowed to $693 million and adjusted operating income reached $1.6 billion, according to reporting on the filing.³

That contrast captures the investor dilemma. Revenue has surged on enterprise demand, but the company’s five largest customers supplied roughly a quarter of revenue, leaving concentration risk alongside growth. Anthropic is also betting heavily that demand will justify an enormous infrastructure buildout: disclosed arrangements with named partners total about $637 billion, including a roughly $161.2 billion Broadcom lease and minimum commitments to Microsoft, Google, Amazon and others.⁴

The company’s own risk disclosures are unusually expansive. Its prospectus warns that advanced systems could pose “catastrophic or existential risks to humanity” if they are misused, weaponized or allowed too much autonomy.³ Yet the governance structure ensures the safety-focused founders retain the final say: a single Class F share held by their LLC will carry 50.1% of the vote after the IPO.⁵

For public investors, Anthropic’s offer is clear but demanding: buy into striking commercial acceleration — and accept that its costs, risks and control will not be conventional.